Tissue tract sealant device

Eisenthal , et al. November 9, 2

Patent Grant D935611

U.S. patent number D935,611 [Application Number D/672,792] was granted by the patent office on 2021-11-09 for tissue tract sealant device. This patent grant is currently assigned to PNEUMONIX MEDICAL, INC.. The grantee listed for this patent is PneumoNIX Medical, Inc.. Invention is credited to Andrew Eisenthal, Shashwat Gupta, Edward Ruppell, III.


United States Patent D935,611
Eisenthal ,   et al. November 9, 2021

Tissue tract sealant device

Claims

CLAIM The ornamental design for the tissue tract sealant device, as shown and described.
Inventors: Eisenthal; Andrew (Brooklyn, NY), Ruppell, III; Edward (San Jose, CA), Gupta; Shashwat (Baltimore, MD)
Applicant:
Name City State Country Type

PneumoNIX Medical, Inc.

Baltimore

MD

US
Assignee: PNEUMONIX MEDICAL, INC. (Baltimore, MD)
Appl. No.: D/672,792
Filed: December 10, 2018

Current U.S. Class: D24/146
Current International Class: 2402
Field of Search: ;D24/146,147,148,127-131,112-114,133,186 ;D7/649 ;D8/93,97,300,310,311,313 ;D19/110,115

References Cited [Referenced By]

U.S. Patent Documents
3330268 July 1967 Goldsmith
D250544 December 1978 Leonard
D269549 June 1983 Gross
D286677 November 1986 Osborne
4670008 June 1987 Von Albertini
5256149 October 1993 Banik et al.
D342136 December 1993 Lafferty
D353668 December 1994 Banks
5387197 July 1995 Smith et al.
5437631 August 1995 Janzen
5571133 November 1996 Yoon
D379515 May 1997 Kuehn
6045570 April 2000 Epstein et al.
6685727 February 2004 Fisher et al.
6692467 February 2004 McFarlane
6770070 March 2004 Balbierz
6790185 September 2004 Fisher et al.
6840952 November 2005 Saker et al.
D582552 December 2008 Berberich
7766891 August 2010 McGurk et al.
D624653 September 2010 Boillat
D630734 January 2011 Speiser
D640785 June 2011 Lee
8029474 October 2011 Chung
D654583 February 2012 Lee-Sepsick
D663832 July 2012 Essinger
D687548 August 2013 Hayashi
D692134 October 2013 Lee-Sepsick
D699341 February 2014 Clark
D715431 October 2014 Vonck
D735331 July 2015 Mastri et al.
D747802 January 2016 Freigang
D748254 January 2016 Freigang
D751704 March 2016 Corydon
D772411 November 2016 Heath
D785173 April 2017 Oberkircher et al.
D796042 August 2017 Eubanks
D831213 October 2018 Kuun
D854148 July 2019 Prinz
D864388 October 2019 Barber
2003/0097079 May 2003 Garcia
2004/0167473 August 2004 Moenning
2004/0236340 November 2004 Yves et al.
2004/0267308 December 2004 Bagadisan
2006/0025749 February 2006 Moenning
2006/0025815 February 2006 McGurk et al.
2008/0294111 November 2008 Tal et al.
2009/0221960 March 2009 Albrecht et al.
2011/0208157 August 2011 Geliebter et al.
2013/0053791 February 2013 Clark
2014/0194685 July 2014 Riek et al.
2014/0128671 August 2014 Riek et al.
2016/0120528 May 2016 Abtin
2016/0000462 July 2016 Pajunk et al.
2016/0296218 October 2016 Uchida et al.
Foreign Patent Documents
0858776 Aug 1998 EP
100786728 Dec 2007 KR
101151310 Sep 2011 KR
20150117517 Oct 2015 KR
2011026935 Mar 2011 WO
2013000536 Jan 2013 WO
2013135354 Sep 2013 WO
2019108618 Jun 2019 WO

Other References

International Search Report for PCT/US18/62799 (dated Apr. 25, 2019). cited by applicant .
International Preliminary Examination Report for PCT/US18/62799 (dated Jun. 2, 2020). cited by applicant.

Primary Examiner: Johnston; Nathan M
Attorney, Agent or Firm: Halloran; Patrick J.

Description



FIG. 1 is a perspective view of a tissue tract sealant device where a portion of the device is transparent revealing a one-way seal inside;

FIG. 2 is a right side view of the tissue tract sealant device;

FIG. 3 is a left side view of the tissue tract sealant device;

FIG. 4 is a front view of the tissue tract sealant device;

FIG. 5 is a back view of the tissue tract sealant device;

FIG. 6 is a top view of the tissue tract sealant device;

FIG. 7 is a bottom view of the tissue tract sealant device;

FIG. 8 is a perspective view of a portion of the tissue tract sealant device thereof including broken line features which form no part of the claimed design; and,

FIG. 9 is a perspective view of a portion of the tissue tract sealant device thereof including alternative broken line features which form no part of the claimed design.

The portions in FIGS. 8-9 shown in broken lines are included to show features that form no part of the claimed design. The tissue tract sealant device is shown with a symbolic break in its length. The appearance of any portion of the tissue tract sealant device between the break lines forms no part of the claimed design.

* * * * *


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed